Why the study?
DOACs are replacing VKAs, but available data on the use of DOACs, particularly dabigatran, for the treatment of left ventricular thrombus remain sparse.
Does dabigatran improve clot resolution in patients with left ventricular thrombus?
Population
15 patients with LVT diagnosed by TTE
Comparison
Dabigatran treatment
Design
Retrospective study
Follow-up
6 months
Authors
Loading...
Dabigatran may be an option for LVT; leaves open need for RCTs to guide practice.
Does dabigatran improve clot resolution in patients with left ventricular thrombus?
Dabigatran appears to be a safe and highly efficacious alternative to warfarin for the rapid resolution of left ventricular thrombus.
Verma et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: